Evaluation of neutron irradiation of pancreatic cancer. Results of a randomized Radiation Therapy Oncology Group clinical trial.
Between 1980-84, the Radiation Therapy Oncology Group conducted a trial in patients with untreated, unresectable localized carcinomas of the pancreas. Patients were randomly chosen to receive either 6,400 cGy with photons, the equivalent dose with a combination of photons and neutrons (mixed-beam irradiation), or neutrons alone. A total of 49 cases were evaluable, of which 23 were treated with photons, 11 with mixed-beam therapy, and 15 with neutrons alone. The median survival time was 5.6 months with neutrons, 7.8 months with mixed-beam radiation, and 8.3 months with photons. The median local control time was 6.7 months with neutrons, 6.5 months with mixed-beam radiation, and 2.6 months with photons. These differences are not statistically significant. Evidence of moderate-to-life-threatening gastrointestinal or hepatic injury was present in three patients treated with neutrons and one patient treated with photons. The causes of this apparent difference are discussed. This study demonstrates there is no evidence to suggest that neutron irradiation, either alone or in combination with photon irradiation, produces better local control or survival rates than photon irradiation.
Thomas
F J
FJ
Department of Radiation Oncology, Cleveland Clinic Foundation, Ohio.
Krall
J
J
Hendrickson
F
F
Griffin
T W
TW
Saxton
J P
JP
Parker
R G
RG
Davis
L W
LW
D000230:Adenocarcinoma / Q000150:complications / Q000401:mortality / Q000532:radiotherapy*; D002986:Clinical Trials as Topic; D005214:Fast Neutrons / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D015337:Multicenter Studies as Topic; D009502:Neutrons / Q000009:adverse effects / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000150:complications / Q000401:mortality / Q000532:radiotherapy*; D011827:Radiation; D011879:Radiotherapy Dosage; D011897:Random Allocation; D012074:Remission Induction